Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc.’s CEO, Michael J. Farrell, executed stock transactions under a pre-established Rule 10b5-1 plan, acquiring and disposing of shares. These transactions, involving common stock and stock options, showcase the company’s executive financial management and strategic planning, potentially influencing ResMed’s market perception and stakeholder interests.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of products related to sleep disorders, respiratory care, and connected health solutions.
YTD Price Performance: 3.10%
Average Trading Volume: 972,805
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.47B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.
